Escitalopram versus nortriptyline: How to let the clinical GENDEP data tell us what they contained

Acta Psychiatrica Scandinavica

Volumn 127, Issue 4, 2013, Pages 328-329

  Bech, P ^a   Allerup, P ^b   Larsen, E R ^c   Csillag, C ^a   Licht, R W ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ESCITALOPRAM; NORTRIPTYLINE;

CONTROLLED STUDY; DEPRESSION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHIATRIST; RATING SCALE; REMISSION;

ANTIDEPRESSIVE AGENTS; CITALOPRAM; CLINICAL TRIALS AS TOPIC; DEPRESSIVE DISORDER, MAJOR; HUMANS; NORTRIPTYLINE; PSYCHOMETRICS; TREATMENT OUTCOME;

EID: 84874954149     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12067     Document Type: Note

References (5)

1. UHER R, FARMER A, MAIER W et al. Measuring depression: comparison and integration of three scales in the GENDEP study. Psychol Med 2008; 38: 289-300.
2. UHER R, MAIER W, Hauser J et al. Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. Br J Psychiatry 2009; 194: 252-259.
3. BECH P. Clinical psychometrics. Wiley Blackwell, 2012.
4. ANDERSON IM. SSRI's versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability. Depress Anxiety 1998; 7(Suppl 1): 11-17.
5. BECH P. The threefold Hamilton Depression Scale. Acta Psychiatr Scand 2012;125:423-424.